Methodological approaches to evaluate the impact of FDA drug safety communications.

Methodological approaches to evaluate the impact of FDA drug safety communications.

Item
http://www.wikidata.org/entity/Q50919971
Evaluating the effectiveness of risk minimisation measures: the application of a conceptual framework to Danish real-world dabigatran data.The US Food and Drug Administration's drug safety recommendations and long-acting beta2-agonist dispensing pattern changes in adult asthma patients: 2003-2012.Antipsychotic Prescribing to Patients Diagnosed with Dementia Without a Diagnosis of Psychosis in the Context of National Guidance and Drug Safety Warnings: Longitudinal Study in UK General Practice.Patient and Physician Perceptions of Drug Safety Information for Sleep Aids: A Qualitative Study.Changes in prescribing and healthcare resource utilization after FDA Drug Safety Communications involving zolpidem-containing medications.The Impact of FDA Regulatory Activities on Incident Dispensing of LABA-Containing Medication: 2005-2011.Evaluation of Risk-Minimization Activities for Cyproterone Acetate 2 mg/Ethinylestradiol 35 µg: A Cross-Sectional Physician Survey.Social Media Impact of the Food and Drug Administration's Drug Safety Communication Messaging About Zolpidem: Mixed-Methods Analysis.Measuring the impact of medicines regulatory interventions - Systematic review and methodological considerations.Media Coverage of FDA Drug Safety Communications about Zolpidem: A Quantitative and Qualitative Analysis.
P2860

Methodological approaches to evaluate the impact of FDA drug safety communications.

Item
http://www.wikidata.org/entity/Q50919971
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Methodological approaches to evaluate the impact of FDA drug safety communications.
@en
Methodological approaches to evaluate the impact of FDA drug safety communications.
@nl
type
label
Methodological approaches to evaluate the impact of FDA drug safety communications.
@en
Methodological approaches to evaluate the impact of FDA drug safety communications.
@nl
prefLabel
Methodological approaches to evaluate the impact of FDA drug safety communications.
@en
Methodological approaches to evaluate the impact of FDA drug safety communications.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Methodological approaches to evaluate the impact of FDA drug safety communications.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P5875
P698